1-1 of 1 results for subject:Reviews
Librarians' tools
- Search time
- 0.203 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:Reviews
- We searched for
- subject_t:Reviews OR subject_ses:12492
Type
House
Session
Year
Department
Member
More
Winterton, Nicholas (1)
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what plans he has to (a) alter the remit and (b) review the framework of the National Institute for Clinical Excellence; and if NICE includes the therapeutic requirements of specific diseases in its assessments of the efficacy of individual drugs. - Including...
To ask the Secretary of State for Health, what plans he has to (a) alter the remit and (b) review the framework of the National Institute for Clinical Excellence; and if NICE includes the therapeutic requirements of specific diseases in its assessments of the efficacy of individual drugs. - Including...
Asked by
Nicholas Winterton
(Conservative)
Answered by
Lord Hutton of Furness
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
20 November 2001
For answer on
10 December 2001
Answered on
10 December 2001
Mr. Nicholas Winterton: To ask the Secretary of State for Health what plans he has to (a) alter the remit and (b) review the
framework of the National Institute for Clinical Excellence; and if NICE includes the therapeutic requirements of specific diseases
in its assessments of the efficacy of individual drugs. [17433]
Mr. Hutton: I refer the hon. Member to the reply given to the hon. Member for Sutton and Cheam (Mr. Burstow) on 22 November 2001,
Official Report, column 416W.
The precise methodology used in appraisals of individual therapies is for the National Institute for Clinical Excellence itself, but
the institute's recommendations always take account of the specific features of the conditions in which the therapies are to be
applied.
Subjects
Accountability; Drugs; Functions; Medical treatments; Reviews; National Institute for Clinical Excellence
Date
10 December 2001
Reference
376 c717W; 17433
House
House of Commons